Tag: #M&A

UCB has entered into a definitive agreement to acquire Candid Therapeutics, securing the rights to cizutamig—a promising bispecific antibody for... Read more

Siegfried Holding AG has finalized the acquisition of Noramco, Extractas Biosciences, and Purisys from affiliates of SK Capital Partners. This... Read more

Cardioline, a leader in cardiac diagnostics and telecardiology, has announced the acquisition of Cardios, a Brazil-based innovator in Holter monitoring... Read more

Chiesi has announced the largest acquisition in its 90-year history, agreeing to purchase KalVista Pharmaceuticals for approximately $1.9 billion. This... Read more

The Vietnamese pharmaceutical sector has witnessed a major ownership transition at Imexpharm Pharmaceutical JSC (HoSE: IMP). Following a successful public... Read more

Gilead Sciences has concluded its merger with Arcellx, a move designed to secure full rights to an investigational cell therapy... Read more

Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon for an enterprise valuation of $11.75 billion in... Read more

Eli Lilly has agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, featuring an upfront... Read more

Servier, a global independent pharmaceutical group, has concluded its tender offer for Day One Biopharmaceuticals, acquiring all outstanding common stock... Read more